MARKET

ACOG

ACOG

Alpha Cognition
NASDAQ
5.43
-0.20
-3.59%
Opening 12:39 03/14 EDT
OPEN
5.54
PREV CLOSE
5.63
HIGH
5.55
LOW
5.43
VOLUME
1.62K
TURNOVER
--
52 WEEK HIGH
17.13
52 WEEK LOW
0.3840
MARKET CAP
86.95M
P/E (TTM)
-1.9063
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACOG last week (0303-0307)?
Weekly Report · 4d ago
Adobe, DICK's Sporting Goods, Dollar General To Report Results As Investors Look To Inflation Report
Seeking Alpha · 6d ago
Weekly Report: what happened at ACOG last week (0224-0228)?
Weekly Report · 03/03 10:48
Weekly Report: what happened at ACOG last week (0217-0221)?
Weekly Report · 02/24 10:48
Weekly Report: what happened at ACOG last week (0210-0214)?
Weekly Report · 02/17 10:46
Alpha Cognition secures additional patent for Zunveyl from USPTO
TipRanks · 02/12 13:42
ALPHA COGNITION SECURES ADDITIONAL U.S. PATENT FOR ZUNVEYL (BENZGALANTAMINE) IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER’S DISEASE
Reuters · 02/12 13:30
Weekly Report: what happened at ACOG last week (0203-0207)?
Weekly Report · 02/10 10:41
More
About ACOG
More
Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.
Recently
Symbol
Price
%Change

Webull offers Alpha Cognition Inc stock information, including NASDAQ: ACOG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACOG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACOG stock methods without spending real money on the virtual paper trading platform.